Science & Technology
SBIR Phase I: Predicting and Diagnosing Alzheimers Disease and Mild Cognitive Impairment by MRI Using Variational Autoencoder and Machine Learning Algorithm
National Science Foundation
Opportunity #: 2500009
Award Ceiling
$303K
Award Floor
$303K
Close Date
Mar 31, 2026
16 days leftTotal Funding
$303K
Expected Awards
1
Posted Date
Apr 9, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2500009
Description
SBIR Phase Phase I award: "SBIR Phase I: Predicting and Diagnosing Alzheimers Disease and Mild Cognitive Impairment by MRI Using Variational Autoencoder and Machine Learning Algorithm" awarded to BioImaginix LLC in Morgantown, West Virginia. Funded by National Science Foundation. Award amount: $303,089. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.